• Pharmacy Practice
    Affordable Medicines Compliance Compounding Drug Approvals Geriatrics
    Hospital/Health System In-Pharmacy Vaccines Law Medication Management News & Trends
    OTC Pharmacist Resources Specialty Pharmacy Technology
  • Disease State
    Allergy Autoimmune Breast Cancer Cardiovascular Cold & Flu
    COVID-19 Dermatology Diabetes Gastroenterology Hematology
    HIV/AIDS Infectious Disease Infusion Lung Cancer Mental Health
    mRNA Technology Neurology Oncology Ophthalmology Orthopedics
    Pain Management Pediatrics Respiratory Urology/Nephrology Women’s Health
  • Health Awareness Month
  • Videos
  • Patient Teaching Aid
  • Publications
    Featured Issue Featured Supplements
  • Conference Coverage
  • Continuing Education
Subscribe
COVID-19 Resources

NEUROLOGY

May 13, 2022

Adverse Neurologic Effects of Electronic Cigarette Use

Neurologic dysfunction—including cerebrovascular dysfunction, neuroinflammation, nicotine addiction, and behavioral and mental health problems—has emerged as a potential adverse effect of vaping.
May 13, 2022

Insomnia Treatment Update With a Focus on Orexin Receptor Antagonists

March 15, 2022

Multiple Sclerosis

February 11, 2022

Understanding and Managing Postural Orthostatic Tachycardia Syndrome

January 14, 2022

Carbamazepine 25 mg/mL in SyrSpend SF PH4

January 14, 2022

The Promise of Alpha-Adrenergics in Parkinson’s Disease

January 14, 2022

Understanding and Managing Postural Orthostatic Tachycardia Syndrome

January 14, 2022

Correcting Dupuytren’s Contracture

January 14, 2022

ADD/ADHD Prevalence and Treatment in Children

January 14, 2022

Alzheimer’s Disease and COVID-19 Share Genetic Risk Factor

January 14, 2022

Helping People Manage Insomnia

January 14, 2022

PTA: Amyotrophic Lateral Sclerosis

December 28, 2021

Study: Mild Cognitive Impairment Cases Resolve Over Time in Some Patients

May 2022

May 2022

In This Issue Digital Magazine Archives Subscription

Related CE

$6.97 Per CE Exam or $59 for 12 Lessons
  • Understanding the Neurologic Manifestations of COVID-19

  • Aducanumab for the Treatment of Alzheimer’s Disease

View More CE
    
Get it on Google Play
U.S. Pharmacist
  • Advertising Contacts
  • Editorial Staff
  • Professional Organizations
  • Submitting a Manuscript
  • Media Kit
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information
  • Careers
  • Classifieds
Copyright © 2000 - 2022 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.

Full Image

Full Image